BRIDGEWATER, N.J., Sept. 1, 2021 /PRNewswire/ -- Insmed
Incorporated Inc. (Nasdaq: INSM), a global biopharmaceutical
company on a mission to transform the lives of patients with
serious and rare diseases, today announced that management will
participate in the following virtual investor events:
- Citi's 16th Annual BioPharma Virtual Conference on
September 8, 2021 at 9:45 a.m. ET in a fireside chat
- The Morgan Stanley 19th Annual Global Healthcare
Conference on September 9, 2021 at
3:30 p.m. ET in a fireside chat
- The H.C. Wainwright 23rd Annual Global Investment
Conference on September 13, 2021 at
7:00 a.m. ET in a fireside chat
available for on-demand viewing
- SVB Leerink CybeRx Series: Neuromuscular, Rare Diseases &
Genetic Medicines Event on September 22,
2021 in 1x1 investor meetings
- The Cantor Fitzgerald Virtual Global Healthcare Conference on
September 27, 2021 at 8:00 a.m. ET in a fireside chat
Each fireside chat will be webcast and can be accessed by
visiting the investor relations section of the Company's website at
www.insmed.com. Each webcast will be archived for a period of 30
days following the respective presentation dates.
About Insmed
Insmed Incorporated is a global biopharmaceutical company on a
mission to transform the lives of patients with serious and rare
diseases. Insmed's first commercial product is a first-in-disease
therapy approved in the United
States, Europe, and
Japan to treat a chronic,
debilitating lung disease. The Company is also progressing a robust
pipeline of investigational therapies targeting areas of serious
unmet need, including neutrophil-mediated inflammatory diseases and
rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a growing
footprint across Europe and in
Japan. For more information, visit
www.insmed.com.
Contact:
Investors:
Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com
Media:
Mandy Fahey
Senior Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/insmed-to-participate-in-five-september-conferences-301366701.html
SOURCE Insmed Incorporated